LEGIONELLA PNEUMOPHILA VIRULENCE FACTORS DEFINED IN VIVO
LEGIONELLA PNEUMOPHILA VIRULENCE FACTORS DEFINED IN VIVO
批准号:
2442371
负责人:
JAMES E KIRBY
金额:
$8.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-07-01 至 2001-06-30
关键词:
Legionella alveolar macrophages bacterial cytopathogenic effect bacterial genetics disease /disorder model gene expression host organism interaction laboratory mouse linkage mapping mutant nucleic acid sequence pathologic process phagocytosis phenotype pneumonia site directed mutagenesis transfection /expression vector transposon /insertion element virulence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The candidate is presently a resident in the Pathology Department at the
Massachusetts General Hospital and has a strong research and clinical
interest in bacterial pathogens. He spent two years at the National
Institutes of Health learning bacterial genetics, and in elective time
this year, is studying Listeria and Salmonella pathogenesis at the
Whitehead Institute. The candidate's career development plan will be
under the mentorship of Ralph Isberg, Ph.D., in the Molecular Biology and
Microbiology Department at Tufts University School of Medicine. This
department has a strong microbial pathogenesis group and has extensive
interactions with the Infectious Disease Department at New England
Medical Center. The candidate's immediate career goal is to acquire
skills necessary for independent study of pathogen host interactions.
During his career development plan, he will, therefore, take course work
to expand his knowledge of bacterial pathogenesis and related disciplines
of cell biology and immunology. In the research project, he will study
virulence mechanisms of Leqionella pneumophila, a cause of severe
pneumonia and a model for pathogens that survive and replicate inside
phagocytic vacuoles. An animal model will be used to identify virulence
mutants that fail to survive during the course of infection. Assays of
the host immune response and bacterial survival during infection will be
used to rapidly categorize virulence mutants and plan further experiments
to define virulence gene function. The candidate's long term career goal
is to become an independent bacterial pathogenesis researcher associated
with an academic pathology department.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10676201
-
项目类别:
-
资助金额:$75.72万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10469007
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10447128
-
项目类别:
-
资助金额:$76.53万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10269053
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials
-
批准号:10686110
-
项目类别:
-
资助金额:$76.68万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity
-
批准号:10242923
-
项目类别:
-
资助金额:$77.26万
-
财政年份:2020
-
负责人:JAMES E KIRBY
-
依托单位:
Fusidic acid derivatization to enhance entry into Gram-negative pathogens
-
批准号:9807473
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2019
-
负责人:JAMES E KIRBY
-
依托单位:
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTION
-
批准号:8891557
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
Plasmid Eviction to Restore Susceptibility in Carbapenem-Resistant Enterobacteriaceae
-
批准号:8954519
-
项目类别:
-
资助金额:$13.05万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
VALIDATION OF A HIGH THROUGHPUT SCREEN FOR KPC PLASMID EVICTION
-
批准号:8990439
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2015
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:8439168
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:9123514
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Novel Antimicrobials Targeting Bacterial Type IV Secretion Systems
-
批准号:8549945
-
项目类别:
-
资助金额:$36.8万
-
财政年份:2012
-
负责人:JAMES E KIRBY
-
依托单位:
Type IV Secretion System Therapeutics
-
批准号:7896197
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2010
-
负责人:JAMES E KIRBY
-
依托单位:
Type IV Secretion System Therapeutics
-
批准号:8041056
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2010
-
负责人:JAMES E KIRBY
-
依托单位:
Non-Antibiotic Selectable Markers for Bacillus Anthracis
-
批准号:7565913
-
项目类别:
-
资助金额:$34.83万
-
财政年份:2008
-
负责人:JAMES E KIRBY
-
依托单位:
Non-Antibiotic Selectable Markers for Bacillus Anthracis
-
批准号:7472107
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2008
-
负责人:JAMES E KIRBY
-
依托单位:
The Basis of Anthrax-Induced Vascular Damage
-
批准号:6985044
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2005
-
负责人:JAMES E KIRBY
-
依托单位:
The Basis of Anthrax-Induced Vascular Damage
-
批准号:7140530
-
项目类别:
-
资助金额:$20.75万
-
财政年份:2005
-
负责人:JAMES E KIRBY
-
依托单位:
LEGIONELLA PNEUMOPHILA VIRULENCE FACTORS DEFINED IN VIVO
-
批准号:2886030
-
项目类别:
-
资助金额:$0.55万
-
财政年份:1996
-
负责人:JAMES E KIRBY
-
依托单位:
海外基金